High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer.
暂无分享,去创建一个
A. Sapino | C. Isella | E. Medico | F. Schmitt | I. Castellano | C. Marchiò | D. Cantarella | G. Mariscotti | R. Arisio | F. Pietribiasi | L. Annaratone | D. Balmativola | T. Renzulli | L. Macrì | Cristina Deambrogio | Elisabetta Cantanna
[1] A. Sapino,et al. Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity , 2011, PloS one.
[2] D. Hicks,et al. Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling. , 2011, Journal of the National Cancer Institute. Monographs.
[3] C. Dumur,et al. Preservation of fine‐needle aspiration specimens for future use in RNA‐based molecular testing , 2011, Cancer cytopathology.
[4] F. Bertucci,et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer , 2011, Breast Cancer Research and Treatment.
[5] Jae K. Lee,et al. Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer , 2010, Clinical Cancer Research.
[6] H. Juhl. Preanalytical aspects: A neglected issue , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[7] C. Isella,et al. The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer , 2009, Oncogene.
[8] R. Crystal,et al. Quality control in microarray assessment of gene expression in human airway epithelium , 2009, BMC Genomics.
[9] S. Michiels,et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. , 2009, The Lancet. Oncology.
[10] F. André,et al. Fine‐needle aspiration for nucleic acid‐ased molecular analyses in breast cancer , 2009, Cancer.
[11] W. Leong,et al. The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers , 2008, BMC Cancer.
[12] A. Sapino,et al. Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue , 2008, Journal of cellular and molecular medicine.
[13] Lajos Pusztai,et al. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. , 2007, The Lancet. Oncology.
[14] Limin Fu,et al. FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data , 2007, BMC Bioinformatics.
[15] J. Ross,et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Maqc Consortium. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.
[17] Daniel W Lin,et al. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[19] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[20] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[21] Yudong D. He,et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. , 2005, Cancer research.
[22] T. Yeatman,et al. Classification of human tumors using gene expression profiles obtained after microarray analysis of fine‐needle aspiration biopsy samples , 2005, Cancer.
[23] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[24] E. Sim,et al. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] J. Stec,et al. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] J. Stec,et al. Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma , 2003, Cancer.
[27] C. Sotiriou,et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer , 2002, Breast Cancer Research.
[28] T. Powles,et al. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] C. Sotiriou,et al. Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. , 2002, The Journal of molecular diagnostics : JMD.
[30] A. Hirano. [Molecular diagnosis of breast cancer]. , 2001, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[31] J. Silverman,et al. Prognostic factors from the fine‐needle aspirate: Breast carcinoma nuclear grade , 1994, Diagnostic cytopathology.
[32] J. Mattick,et al. 'Touchdown' PCR to circumvent spurious priming during gene amplification. , 1991, Nucleic acids research.
[33] E Medico,et al. The GAB 2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated to metastatic progression of breast cancer , 2022 .